Inventor · disambiguated record
Jiawang Liu
Also filed as: LIU JIAWANG
14 granted patents·8 pending applications·20 citations·filing 2010–2023
87Inventor score
Files withBEIJING HANMI PHARMACEUTICAL CO LTD13Beijing hanmi pharm co ltd3XAVIER UNIV OF LOUISIANA3BECKMAN BARBARA S1EVONIK DEGUSSA GMBH1
Top patents by PatentIndex Score
22 records- 0185US10696702B2Propyl-bridged diphosphine ligands for alkoxycarbonylationEVONIK DEGUSSA GMBH·Filed 2019·Granted Jun 30, 2020·2 cites·24 claims
- 0282US11319378B2Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing the sameBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted May 3, 2022·3 cites·9 claims
- 0382US9789202B2Method for treating cancer using an interferon alpha conjugateJUNG SUNG YOUB·Filed 2012·Granted Oct 17, 2017·7 cites·17 claims
- 0477US11498977B2Heterodimeric immunoglobulin constructs and preparation methods thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 15, 2022·2 cites·37 claims
- 0575US11072651B2Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibodyBeijing hanmi pharm co ltd·Filed 2017·Granted Jul 27, 2021·2 cites·17 claims
- 0674US11117967B2Antibody specifically binding to PD-1 and functional fragment thereofBeijing hanmi pharm co ltd·Filed 2017·Granted Sep 14, 2021·2 cites·37 claims
- 0773US11753471B2Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing sameBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 12, 2023·1 cites·9 claims
- 0869US11827697B2Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 28, 2023·1 cites·24 claims
- 0956US2025277044A1Antibody specifically binding to 4-1bb and antigen-binding fragment of antibodyBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1055US2025361303A1Formulations for anti-pd-l1/anti-4-1bb bispecific antibodiesBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1155US2024301068A1Antibody specifically binding with pd-l1 and antigen-binding fragment of antibodyBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1255US2025277031A1Antibody specifically binding to cd47 and antigen-binding fragment thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1354US2024034801A1Anti-pd-l1/anti-4-1bb natural antibody structure-like heterodimeric form bispecific antibody and preparation thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1454US2024052037A1Anti-pd-l1/anti-cd47 natural antibody structure-like heterodimeric form bispecific antibody and preparation thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1548US11708381B2Inhibitors of androgen receptor signalingXAVIER UNIV OF LOUISIANA·Filed 2017·Granted Jul 25, 2023·0 cites·21 claims
- 1646US11739151B2Anti-PD-L1/anti-CD47 bispecific antibodyBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 29, 2023·0 cites·18 claims
- 1745US12325743B2Anti-TNFα/anti IL-17A natural antibody structure-like heterodimer form of bispecific antibody and preparation method thereforBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 10, 2025·0 cites·23 claims
- 1844US11591409B2Anti-PD-L1/anti-PD-1 natural antibody structure-like heterodimeric bispecific antibody and preparation thereofBeijing hanmi pharm co ltd·Filed 2018·Granted Feb 28, 2023·0 cites·8 claims
- 1944US11046715B2Boronic derivatives of hydroxamates as anticancer agentsXAVIER UNIV OF LOUISIANA·Filed 2017·Granted Jun 29, 2021·0 cites·19 claims
- 2039US2019233442A1Selective estrogen receptor down-regulators (serds)XAVIER UNIV OF LOUISIANA·Filed 2017·Application pending·0 cites
- 2132US2016340422A1Bifunctional fusion protein, preparation method therefor, and use thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
- 2219US8853452B2Compounds, their syntheses, compositions, and methods to treat cancerBECKMAN BARBARA S·Filed 2010·Granted Oct 7, 2014·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Jiawang Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →